 Christopher Evans
Concepts (490)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucus | 16 | 2025 | 79 | 5.140 |
Why?
| | Mucins | 24 | 2025 | 74 | 4.810 |
Why?
| | Mucin-5B | 24 | 2025 | 224 | 2.830 |
Why?
| | Mucin 5AC | 19 | 2025 | 70 | 2.600 |
Why?
| | Lung | 38 | 2025 | 4046 | 2.390 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 45 | 1.850 |
Why?
| | Bronchial Hyperreactivity | 6 | 2025 | 111 | 1.820 |
Why?
| | Respiratory Mucosa | 19 | 2025 | 322 | 1.810 |
Why?
| | Asthma | 11 | 2025 | 2285 | 1.770 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 50 | 1.620 |
Why?
| | Idiopathic Pulmonary Fibrosis | 13 | 2025 | 652 | 1.330 |
Why?
| | Expectorants | 4 | 2023 | 24 | 1.200 |
Why?
| | Fucosyltransferases | 1 | 2025 | 33 | 0.930 |
Why?
| | Animals | 68 | 2025 | 36915 | 0.910 |
Why?
| | Electric Conductivity | 1 | 2024 | 95 | 0.900 |
Why?
| | Vagus Nerve | 4 | 2023 | 87 | 0.890 |
Why?
| | Alveolar Epithelial Cells | 3 | 2024 | 114 | 0.890 |
Why?
| | Electrolytes | 1 | 2024 | 59 | 0.890 |
Why?
| | Bronchioles | 4 | 2024 | 23 | 0.840 |
Why?
| | Quantum Dots | 3 | 2012 | 36 | 0.830 |
Why?
| | Mice | 47 | 2025 | 17775 | 0.810 |
Why?
| | Lung Injury | 3 | 2024 | 214 | 0.810 |
Why?
| | Reflex | 1 | 2023 | 69 | 0.790 |
Why?
| | Respiratory System | 6 | 2020 | 158 | 0.780 |
Why?
| | Disulfides | 2 | 2022 | 107 | 0.730 |
Why?
| | Disease Models, Animal | 20 | 2025 | 4281 | 0.700 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 69 | 0.690 |
Why?
| | Homeostasis | 6 | 2020 | 622 | 0.680 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2024 | 1041 | 0.670 |
Why?
| | Mice, Inbred C57BL | 29 | 2025 | 5766 | 0.650 |
Why?
| | Peptides | 1 | 2024 | 981 | 0.590 |
Why?
| | Pulmonary Alveoli | 5 | 2025 | 405 | 0.570 |
Why?
| | Mice, Transgenic | 14 | 2020 | 2182 | 0.560 |
Why?
| | Hypersensitivity | 1 | 2021 | 256 | 0.560 |
Why?
| | Eosinophilia | 1 | 2020 | 213 | 0.560 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 20 | 0.500 |
Why?
| | Epithelial Cells | 10 | 2019 | 1097 | 0.500 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 109 | 0.500 |
Why?
| | Selenium Compounds | 2 | 2012 | 21 | 0.490 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.490 |
Why?
| | Cadmium Compounds | 2 | 2012 | 32 | 0.490 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 504 | 0.450 |
Why?
| | Macrophages | 4 | 2024 | 1547 | 0.450 |
Why?
| | Uteroglobin | 6 | 2024 | 23 | 0.420 |
Why?
| | Lung Diseases | 2 | 2018 | 768 | 0.420 |
Why?
| | Inflammation | 11 | 2022 | 2817 | 0.400 |
Why?
| | Eosinophils | 4 | 2021 | 329 | 0.390 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2490 | 0.390 |
Why?
| | Cadmium | 1 | 2012 | 70 | 0.390 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1271 | 0.380 |
Why?
| | Surface-Active Agents | 1 | 2012 | 91 | 0.380 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 1088 | 0.370 |
Why?
| | Intracellular Space | 1 | 2012 | 69 | 0.370 |
Why?
| | Immunity, Innate | 5 | 2019 | 832 | 0.360 |
Why?
| | Mice, Knockout | 13 | 2025 | 2998 | 0.350 |
Why?
| | Glycosylation | 2 | 2025 | 162 | 0.350 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1255 | 0.350 |
Why?
| | Ribonucleases | 3 | 2000 | 55 | 0.350 |
Why?
| | Humans | 51 | 2025 | 136899 | 0.350 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 11 | 0.340 |
Why?
| | Transcription Factors | 1 | 2018 | 1715 | 0.330 |
Why?
| | Bronchi | 3 | 2016 | 259 | 0.330 |
Why?
| | Exocytosis | 3 | 2019 | 89 | 0.320 |
Why?
| | Gene Expression Regulation | 6 | 2025 | 2615 | 0.320 |
Why?
| | Cilia | 4 | 2022 | 186 | 0.320 |
Why?
| | Polymers | 2 | 2024 | 495 | 0.320 |
Why?
| | Mucous Membrane | 4 | 2021 | 125 | 0.300 |
Why?
| | Airway Obstruction | 2 | 2016 | 162 | 0.290 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 608 | 0.280 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 854 | 0.270 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 97 | 0.260 |
Why?
| | Ovalbumin | 7 | 2015 | 183 | 0.250 |
Why?
| | Munc18 Proteins | 2 | 2019 | 24 | 0.250 |
Why?
| | Bordetella bronchiseptica | 1 | 2025 | 2 | 0.250 |
Why?
| | Bordetella Infections | 1 | 2025 | 4 | 0.250 |
Why?
| | Gene Expression | 4 | 2018 | 1505 | 0.240 |
Why?
| | Oligosaccharides | 1 | 2025 | 61 | 0.240 |
Why?
| | Colloids | 3 | 2019 | 60 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 498 | 0.230 |
Why?
| | Phagocytosis | 3 | 2016 | 379 | 0.230 |
Why?
| | Hydrogen Bonding | 1 | 2024 | 168 | 0.220 |
Why?
| | Th2 Cells | 4 | 2017 | 176 | 0.210 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 3 | 2024 | 45 | 0.210 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 654 | 0.210 |
Why?
| | Energy Metabolism | 2 | 2024 | 892 | 0.200 |
Why?
| | Salts | 1 | 2023 | 37 | 0.200 |
Why?
| | Glycosyltransferases | 1 | 2022 | 13 | 0.200 |
Why?
| | Bleomycin | 5 | 2024 | 247 | 0.200 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 11 | 0.200 |
Why?
| | Female | 32 | 2024 | 72703 | 0.200 |
Why?
| | Regeneration | 1 | 2024 | 194 | 0.200 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.200 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 9 | 0.200 |
Why?
| | Bronchiectasis | 1 | 2024 | 111 | 0.200 |
Why?
| | MicroRNAs | 3 | 2019 | 703 | 0.190 |
Why?
| | Glycoproteins | 2 | 2022 | 345 | 0.190 |
Why?
| | Golgi Apparatus | 1 | 2022 | 100 | 0.190 |
Why?
| | Glycolysis | 1 | 2024 | 319 | 0.190 |
Why?
| | Fibroblasts | 2 | 2025 | 990 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2416 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 501 | 0.190 |
Why?
| | Colon | 2 | 2022 | 270 | 0.190 |
Why?
| | Pulmonary Emphysema | 1 | 2024 | 284 | 0.190 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 64 | 0.190 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1739 | 0.180 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 27 | 0.180 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 191 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 413 | 0.180 |
Why?
| | Metaplasia | 5 | 2008 | 60 | 0.180 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 397 | 0.180 |
Why?
| | Substance P | 1 | 2000 | 43 | 0.170 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 224 | 0.170 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 392 | 0.170 |
Why?
| | Leukocyte Count | 1 | 2021 | 331 | 0.170 |
Why?
| | Blood Proteins | 3 | 2000 | 250 | 0.170 |
Why?
| | Mustard Gas | 1 | 2021 | 103 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 114 | 0.170 |
Why?
| | Male | 24 | 2024 | 67308 | 0.170 |
Why?
| | Antigens | 4 | 2007 | 358 | 0.160 |
Why?
| | Allergens | 2 | 2015 | 405 | 0.160 |
Why?
| | Syndecan-1 | 1 | 2019 | 38 | 0.160 |
Why?
| | Gene Targeting | 2 | 2018 | 83 | 0.160 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 87 | 0.160 |
Why?
| | Butadienes | 2 | 2009 | 37 | 0.160 |
Why?
| | Polystyrenes | 2 | 2009 | 36 | 0.160 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 216 | 0.150 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 130 | 0.150 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 75 | 0.150 |
Why?
| | Interleukin-13 | 3 | 2019 | 149 | 0.150 |
Why?
| | Hypoxia | 2 | 2017 | 1106 | 0.150 |
Why?
| | Dexamethasone | 1 | 2001 | 374 | 0.150 |
Why?
| | Cysts | 1 | 2019 | 111 | 0.150 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 313 | 0.150 |
Why?
| | Guinea Pigs | 5 | 2005 | 162 | 0.150 |
Why?
| | Paraquat | 1 | 2018 | 14 | 0.140 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 480 | 0.140 |
Why?
| | Herbicides | 1 | 2018 | 27 | 0.140 |
Why?
| | Macrophage Activation | 1 | 2019 | 201 | 0.140 |
Why?
| | Methacholine Chloride | 2 | 2015 | 52 | 0.140 |
Why?
| | Signal Transduction | 8 | 2022 | 5077 | 0.140 |
Why?
| | Colitis | 1 | 2020 | 255 | 0.140 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 27 | 0.140 |
Why?
| | Schistosoma | 1 | 2017 | 28 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 146 | 0.130 |
Why?
| | Transgenes | 1 | 2018 | 180 | 0.130 |
Why?
| | Mucin-2 | 1 | 2016 | 3 | 0.130 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 132 | 0.130 |
Why?
| | Mast Cells | 2 | 2021 | 146 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1769 | 0.130 |
Why?
| | Leukocytes | 2 | 2016 | 311 | 0.130 |
Why?
| | Bacteria | 3 | 2020 | 855 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2018 | 220 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2001 | 596 | 0.130 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 25 | 0.130 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 30 | 0.130 |
Why?
| | Survival Analysis | 3 | 2018 | 1320 | 0.130 |
Why?
| | Cytokines | 6 | 2021 | 2078 | 0.130 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 121 | 0.130 |
Why?
| | Bronchoconstriction | 2 | 2011 | 32 | 0.130 |
Why?
| | Neurons | 2 | 2005 | 1608 | 0.120 |
Why?
| | Neutrophils | 3 | 2017 | 1237 | 0.120 |
Why?
| | Thiocyanates | 1 | 2015 | 31 | 0.120 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 7 | 0.120 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 6 | 0.120 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 49 | 0.120 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 4 | 0.120 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.120 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 9 | 0.120 |
Why?
| | Models, Biological | 2 | 2013 | 1774 | 0.120 |
Why?
| | Mutation | 5 | 2018 | 3948 | 0.110 |
Why?
| | Polysaccharides | 1 | 2014 | 87 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 284 | 0.110 |
Why?
| | Cell Line | 4 | 2019 | 2847 | 0.110 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1458 | 0.110 |
Why?
| | Species Specificity | 1 | 2015 | 593 | 0.110 |
Why?
| | Ear, Middle | 1 | 2013 | 92 | 0.100 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 763 | 0.100 |
Why?
| | Bed Rest | 1 | 2013 | 14 | 0.100 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 487 | 0.100 |
Why?
| | Smoking | 2 | 2018 | 1633 | 0.100 |
Why?
| | Semiconductors | 1 | 2012 | 40 | 0.100 |
Why?
| | Genes, Essential | 1 | 2012 | 22 | 0.100 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 36 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 455 | 0.100 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3396 | 0.100 |
Why?
| | Muscle Development | 1 | 2013 | 111 | 0.100 |
Why?
| | Crystallization | 1 | 2012 | 144 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 974 | 0.100 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 59 | 0.090 |
Why?
| | Polymerization | 1 | 2012 | 126 | 0.090 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 223 | 0.090 |
Why?
| | Base Sequence | 3 | 2017 | 2180 | 0.090 |
Why?
| | Sarcopenia | 1 | 2013 | 82 | 0.090 |
Why?
| | Fibrosis | 2 | 2024 | 552 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2013 | 248 | 0.090 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.090 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.090 |
Why?
| | Genes, ras | 2 | 2009 | 96 | 0.090 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 11 | 0.090 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 10 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2018 | 934 | 0.090 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 21 | 0.090 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 59 | 0.090 |
Why?
| | Integrases | 2 | 2010 | 121 | 0.090 |
Why?
| | Sepsis | 1 | 2017 | 610 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2013 | 362 | 0.090 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 51 | 0.090 |
Why?
| | Phosphines | 1 | 2010 | 17 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 33118 | 0.080 |
Why?
| | Th1 Cells | 1 | 2011 | 143 | 0.080 |
Why?
| | Goblet Cells | 2 | 2020 | 22 | 0.080 |
Why?
| | Apoptosis | 3 | 2014 | 2542 | 0.080 |
Why?
| | DNA Primers | 2 | 2009 | 514 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1079 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3282 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 451 | 0.080 |
Why?
| | Latex | 1 | 2009 | 9 | 0.080 |
Why?
| | Pentanes | 1 | 2009 | 11 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 1012 | 0.080 |
Why?
| | Hemiterpenes | 1 | 2009 | 11 | 0.080 |
Why?
| | Curcumin | 1 | 2009 | 30 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 807 | 0.080 |
Why?
| | Elastomers | 1 | 2009 | 28 | 0.080 |
Why?
| | Emulsions | 1 | 2009 | 54 | 0.080 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 219 | 0.080 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 596 | 0.070 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2013 | 560 | 0.070 |
Why?
| | Cell Extracts | 1 | 2008 | 21 | 0.070 |
Why?
| | Electric Stimulation | 2 | 2000 | 272 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 116 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 2175 | 0.070 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 184 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 882 | 0.070 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 48 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 616 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2017 | 2837 | 0.070 |
Why?
| | Gait | 1 | 2010 | 279 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2008 | 198 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2007 | 163 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 226 | 0.070 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 162 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2007 | 239 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 346 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 387 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 329 | 0.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 429 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2010 | 771 | 0.060 |
Why?
| | Time Factors | 3 | 2011 | 6802 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 47 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2005 | 33 | 0.060 |
Why?
| | Bordetella pertussis | 1 | 2025 | 3 | 0.060 |
Why?
| | Walking | 1 | 2010 | 514 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1901 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 328 | 0.060 |
Why?
| | Nasopharynx | 1 | 2025 | 75 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1790 | 0.060 |
Why?
| | Nasal Mucosa | 1 | 2025 | 109 | 0.060 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 5 | 0.060 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 631 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 21402 | 0.060 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.060 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 353 | 0.060 |
Why?
| | Aerosols | 3 | 2010 | 176 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 846 | 0.050 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 640 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 599 | 0.050 |
Why?
| | Pneumonia | 3 | 2017 | 631 | 0.050 |
Why?
| | Organoids | 1 | 2024 | 110 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 270 | 0.050 |
Why?
| | Trachea | 2 | 2020 | 235 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 344 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2143 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1699 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 300 | 0.050 |
Why?
| | Ions | 1 | 2023 | 72 | 0.050 |
Why?
| | Transcriptome | 2 | 2019 | 973 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3290 | 0.050 |
Why?
| | Diffusion | 1 | 2023 | 120 | 0.050 |
Why?
| | Adult | 3 | 2021 | 37595 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2901 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1863 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 3201 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 309 | 0.050 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.050 |
Why?
| | Antibodies | 2 | 2000 | 414 | 0.040 |
Why?
| | Mechlorethamine | 1 | 2021 | 60 | 0.040 |
Why?
| | ErbB Receptors | 2 | 2018 | 616 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 195 | 0.040 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 9 | 0.040 |
Why?
| | Quinuclidines | 1 | 2000 | 9 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 845 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 83 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 107 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 94 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 198 | 0.040 |
Why?
| | Stem Cells | 1 | 2024 | 589 | 0.040 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.040 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.040 |
Why?
| | Cross Protection | 1 | 2019 | 5 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 2000 | 246 | 0.040 |
Why?
| | Haemophilus Infections | 2 | 2010 | 42 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 16 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 765 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 161 | 0.040 |
Why?
| | Protein Binding | 2 | 2017 | 2222 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 414 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 680 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2014 | 2471 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 4 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 7 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 35 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 68 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 175 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 416 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 35 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 259 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 313 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 207 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 414 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 60 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 7 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 217 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 356 | 0.040 |
Why?
| | Sputum | 1 | 2020 | 310 | 0.040 |
Why?
| | Larva | 1 | 2019 | 221 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1324 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 2140 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 148 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1271 | 0.040 |
Why?
| | Immunologic Techniques | 1 | 1997 | 40 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 544 | 0.040 |
Why?
| | Body Composition | 2 | 2013 | 665 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 229 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 176 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 784 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.030 |
Why?
| | Biopsy | 1 | 2001 | 1130 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 99 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 139 | 0.030 |
Why?
| | Acetylcholine | 1 | 1997 | 186 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 664 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 160 | 0.030 |
Why?
| | Thermodynamics | 2 | 2009 | 421 | 0.030 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 20 | 0.030 |
Why?
| | NF-kappa B | 2 | 2012 | 685 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 792 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 16 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 58 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 33 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 13 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 31 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 313 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 61 | 0.030 |
Why?
| | Aged | 5 | 2015 | 23641 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3528 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 240 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 4 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2066 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 620 | 0.030 |
Why?
| | Child | 3 | 2021 | 21896 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 62 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 982 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 117 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 567 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 232 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 324 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1308 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 277 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 682 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2014 | 318 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11013 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 4204 | 0.030 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Whole Body Imaging | 1 | 2013 | 25 | 0.030 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 6 | 0.030 |
Why?
| | E-Box Elements | 1 | 2012 | 5 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1061 | 0.020 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 31 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 145 | 0.020 |
Why?
| | Ligands | 1 | 2014 | 665 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 138 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2012 | 152 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 251 | 0.020 |
Why?
| | Cell Separation | 1 | 2013 | 319 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 644 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2012 | 227 | 0.020 |
Why?
| | Nanoparticles | 1 | 2017 | 483 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 402 | 0.020 |
Why?
| | Cecum | 1 | 2011 | 33 | 0.020 |
Why?
| | Arthropod Proteins | 1 | 2011 | 4 | 0.020 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 16 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 229 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 36 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 393 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 394 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 72 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 357 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 849 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 475 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 268 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 299 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1227 | 0.020 |
Why?
| | Habits | 1 | 2010 | 46 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 770 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 986 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 948 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 158 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2670 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1906 | 0.020 |
Why?
| | Speech | 1 | 2010 | 77 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4011 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1684 | 0.020 |
Why?
| | Survival | 1 | 2009 | 38 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 42 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 309 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 201 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 212 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 337 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1185 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 332 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 221 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 208 | 0.020 |
Why?
| | Leg | 1 | 2010 | 223 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 129 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1302 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 82 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 12 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 111 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 137 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 19 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 176 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1980 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 120 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 130 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1111 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 92 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 790 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 463 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 268 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 681 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 328 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 195 | 0.020 |
Why?
| | Exons | 1 | 2008 | 349 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 844 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 886 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 203 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 58 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 379 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1122 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 8 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 26 | 0.020 |
Why?
| | Body Weight | 1 | 2010 | 973 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1972 | 0.020 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 27 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 366 | 0.020 |
Why?
| | Motor Activity | 1 | 2010 | 722 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 607 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 664 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1773 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 888 | 0.010 |
Why?
| | History, 20th Century | 1 | 2006 | 324 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1434 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 779 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5675 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6043 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1242 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1400 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2744 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1167 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 13157 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9408 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 4 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 7 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 24 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 16 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 16 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 33 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 28 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 95 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7552 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 6715 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|